K. Holme

发表

Drilling fluid shear stress overshoot behavior

Marvin A. Tung, M. A. Tung, R. A. Speers, 1987 .

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Stephen K Burley, Spencer Emtage, Shane Atwell, 2009, Molecular Cancer Therapeutics.

Inhibition of T315I Bcr-Abl and Other Imatinib-Resistant Bcr-Abl Mutants by the Selective Abl Kinase Inhibitor SGX70393.

S. Burley, A. Corbin, M. Deininger, 2006 .

Chitosan N-sulfate. A water-soluble polyelectrolyte.

K. Holme, A. Perlin, 1997, Carbohydrate research.

Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.

K. Holme, B. Herold, S. Gerber, 1995, Virology.

Preparation and characterization of N-[2-(glycosyloxy)-ethyl]chitosan derivatives☆

L. Hall, K. Holme, 1992 .

Cholesteric properties of cellulose acetate and triacetate in trifluoroacetic acid

K. Holme, D. Gray, A. Ritcey, 1988 .

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.

K. Holme, J. Castellot, R. Tressler, 1996, Glycobiology.

Chitosan N-sulfate. A water-soluble polyelectrolyte.

K. Holme, A. Perlin, 1997, Carbohydrate research.

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

D. Kasper, K. Holme, M. Wessels, 1990, The Journal of clinical investigation.

An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.

D. Kasper, K. Holme, M. Wessels, 1990, The Journal of biological chemistry.

Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2

K. Holme, C. King, J. Hutchinson, 2012, Journal of clinical pharmacology.

Solution interactions and rheology of N-[2-(glycosyloxy)-ethyl]chitosan derivatives

M. A. Tung, L. Hall, R. Speers, 1992 .

Modulation of Nonspecific Binding in Ultrafiltration Protein Binding Studies

K. Holme, P. Sinko, T. Hollenbeck, 2003, Pharmaceutical Research.

Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans. 2-D spectra of the chondroitin sulfates.

K. Holme, A. Perlin, 1989, Carbohydrate research.

A Detailed Evaluation of the Structural and Biological Effects of Alkaline O-Desulfation Reactions of Heparin

K. Holme, W. Liang, L. Lam, 1996 .

Heparin in molluscs: chemical, enzymatic degradation and 13C and 1H n.m.r. spectroscopical evidence for the maintenance of the structure through evolution.

K. Holme, H. Nader, E. Santos, 1989, International journal of biological macromolecules.

An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.

K. Holme, W. Liang, C. Foxall, 1995, Analytical biochemistry.

Observations on cation-binding characteristics and nuclear magnetic resonance spectra of the N-carboxymethyl and N-acetyl analogs of heparin

K. Holme, R. Rej, A. Perlin, 1990 .

Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor.

K. Holme, Z. Yang, W. Liang, 1994, Glycobiology.

Marked stereoselectivity in the binding of copper ions by heparin. Contrasts with the binding of gadolinium and calcium ions.

K. Holme, R. Rej, A. Perlin, 1990, Carbohydrate research.

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

K. Holme, C. Page, D. Tyrrell, 1999, Advances in pharmacology.

Formation of 1,2-O-(1,2-ethanediyl)-β-d-mannopyranose in a neighboring-group participation reaction of 2-O-(2-hydroxyethyl)-d-mannose

K. Holme, A. Perlin, M. Tomaszewski, 1991 .

Novel metal chelating chitosan derivative: attachment of iminodiacetate moieties via a hydrophilic spacer group

L. Hall, K. Holme, 1991 .

Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer.

Kevin Holme, K. Holme, G. Grass, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Chemical composition, particle size range, and biological activity of some low molecular weight heparin derivatives.

K. Holme, T. Racey, G. Neville, 1990, Journal of pharmaceutical sciences.

3-Azi-1-methoxybutyl beta-D-galactopyranoside, a photoaffinity label for monoclonal antigalactan antibodies of the VH GAL 39.1/55.1 gene-family.

J. Lehmann, K. Holme, H. Lay, 1988, Carbohydrate research.

Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy.

K. Holme, G. Neville, A. Perlin, 1989, Journal of pharmaceutical sciences.

SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib

Stephen K Burley, Sean Buchanan, Kevin Holme, 2008, Proceedings of the National Academy of Sciences.

Analysis of conifer leaf free amino acids by gas-liquid chromatography☆

K. Holme, S. Mackenzie, 1984 .

Synthesis and evaluation of chitosan-based, affinity-chromatography materials.

S. Withers, L. Hall, K. Holme, 1988, Carbohydrate research.

Matrix metalloproteinase inhibitors: a structure-activity study.

K. Holme, D. Grobelny, D. Levy, 1998, Journal of medicinal chemistry.

CHITOSAN DERIVATIVES BEARING C10-ALKYL GLYCOSIDE BRANCHES : A TEMPERATURE-INDUCED GELLING POLYSACCHARIDE

L. Hall, K. Holme, 1991 .

Effects of nonanticoagulant heparin on cardiovascular and hepatocellular function after hemorrhagic shock.

Z. Ba, I. Chaudry, K. Holme, 1996, The American journal of physiology.

Measurement of proton spin-lattice relaxation rates of model phantoms in chemical imaging

L. Hall, K. Holme, S. Sukumar, 1985 .